MiNK Therapeutics Insider Trades

INKT

Track insider trading activity from MiNK Therapeutics executives and directors. See which insiders are buying and selling INKT stock.

Trades Last 12 Months

INKT Price

All Insider Trades for MiNK Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvese Brian Director
Holding Value $687k 54,770 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 1,633 shares
$10.95
$12.55
Holding Value $58.9k 4,691 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5k 1,233 shares
$10.95
$12.55
Wiinberg Ulf Director
Holding Value $300k 23,929 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 1,279 shares
$10.95
$12.55
Behner Peter Director
Holding Value $306k 24,404 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.3k 1,485 shares
$10.95
$12.55
Ryan Barbara Director
Holding Value $296k 23,591 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 1,622 shares
$10.95
$12.55
Buell Jennifer Chief Executive Officer
Holding Value $853k 67,966 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$906k 81,474 shares
$11.12
$12.55
Wiinberg Ulf Director
Holding Value $67.7k 5,395 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 5,395 shares
$11.12
$12.55
Holding Value $240k 19,126 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5k 1,218 shares
$11.09
$12.55
Van Dijk Marcus Antonius Chief Scientific Officer
Holding Value $2.15M 171,078 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 186,078 shares
$8.70
$12.55
Agenus Inc 10% owner
Holding Value $273M 21,772,863 shares
Last Trade
Oct 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.72k 429 shares
$11.00
$12.55
Baldoni John Director
Holding Value $517k 41,193 shares
Last Trade
Sep 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 9,846 shares
$14.60
$12.55
Armen Garo H Director
Holding Value $23.4M 1,866,400 shares
Last Trade
May 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.58M 100,000 shares
$15.80
$12.55
Holding Value $0 0 shares
Last Trade
Oct 13, 2021 Sale
No data
No data
$12.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up